Filed: 2/14/2024ACC: 0001964437-24-000002
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $261.25M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$261.25M
Total AUM (reported)
11.60M
Total Shares
Allocation by class
COM$187.77M71.9%
COM NEW$37.42M14.3%
SPONSORED ADR$36.06M13.8%
Portfolio Concentration
Top 3$87.56M33.5%
4–10$106.90M40.9%
11–25$66.79M25.6%
Top 3 weight
33.5%
Top 10 weight
74.4%
Voting Authority Distribution
Total shares with voting rights: 11.60M
Sole
Full voting authority
11.60M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
CYTOKINETICS INC
SOLEShares448.14K
TypeSH
Market value$37.42M
14.32%
Sole
448.14K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares787.13K
TypeSH
Market value$28.01M
10.72%
Sole
787.13K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.81M
TypeSH
Market value$22.14M
8.48%
Sole
1.81M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares51.17K
TypeSH
Market value$19.47M
7.45%
Sole
51.17K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares750.25K
TypeSH
Market value$17.72M
6.78%
Sole
750.25K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares131.76K
TypeSH
Market value$16.60M
6.35%
Sole
131.76K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares1.10M
TypeSH
Market value$16.18M
6.19%
Sole
1.10M
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares664.28K
TypeSH
Market value$14.23M
5.45%
Sole
664.28K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares119.19K
TypeSH
Market value$11.49M
4.40%
Sole
119.19K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares518.80K
TypeSH
Market value$11.21M
4.29%
Sole
518.80K
Shared
0.00
None
0.00
MERUS N V
SOLEShares389.33K
TypeSH
Market value$10.71M
4.10%
Sole
389.33K
Shared
0.00
None
0.00
ITEOS THERAPEUTICS INC
SOLEShares828.23K
TypeSH
Market value$9.07M
3.47%
Sole
828.23K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares142.93K
TypeSH
Market value$8.56M
3.27%
Sole
142.93K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares32.47K
TypeSH
Market value$8.40M
3.22%
Sole
32.47K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares990.66K
TypeSH
Market value$7.61M
2.91%
Sole
990.66K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares212.34K
TypeSH
Market value$6.13M
2.35%
Sole
212.34K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares756.68K
TypeSH
Market value$4.45M
1.70%
Sole
756.68K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares64.78K
TypeSH
Market value$3.74M
1.43%
Sole
64.78K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares199.97K
TypeSH
Market value$2.84M
1.09%
Sole
199.97K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares10.33K
TypeSH
Market value$1.98M
0.76%
Sole
10.33K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares160.07K
TypeSH
Market value$1.46M
0.56%
Sole
160.07K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares1.39M
TypeSH
Market value$1.09M
0.42%
Sole
1.39M
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares52.78K
TypeSH
Market value$751.6K
0.29%
Sole
52.78K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYTOKINETICS INCSOLE | COM NEW | 448.14K | SH | $37.42M 14.32% | 448.14K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 787.13K | SH | $28.01M 10.72% | 787.13K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.81M | SH | $22.14M 8.48% | 1.81M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 51.17K | SH | $19.47M 7.45% | 51.17K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 750.25K | SH | $17.72M 6.78% | 750.25K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 131.76K | SH | $16.60M 6.35% | 131.76K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 1.10M | SH | $16.18M 6.19% | 1.10M | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 664.28K | SH | $14.23M 5.45% | 664.28K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 119.19K | SH | $11.49M 4.40% | 119.19K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 518.80K | SH | $11.21M 4.29% | 518.80K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 389.33K | SH | $10.71M 4.10% | 389.33K | 0.00 | 0.00 |
ITEOS THERAPEUTICS INCSOLE | COM | 828.23K | SH | $9.07M 3.47% | 828.23K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 142.93K | SH | $8.56M 3.27% | 142.93K | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 32.47K | SH | $8.40M 3.22% | 32.47K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 990.66K | SH | $7.61M 2.91% | 990.66K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 212.34K | SH | $6.13M 2.35% | 212.34K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 756.68K | SH | $4.45M 1.70% | 756.68K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 64.78K | SH | $3.74M 1.43% | 64.78K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 199.97K | SH | $2.84M 1.09% | 199.97K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 10.33K | SH | $1.98M 0.76% | 10.33K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 160.07K | SH | $1.46M 0.56% | 160.07K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM | 1.39M | SH | $1.09M 0.42% | 1.39M | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | COM | 52.78K | SH | $751.6K 0.29% | 52.78K | 0.00 | 0.00 |